Standard BioTools Inc.

NASDAQ: FLDM · Real-Time Price · USD
3.71
-0.28 (-7.02%)
At close: Apr 06, 2022, 6:00 AM

Standard BioTools Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
26.5M 38.27M 28.5M 31.02M 32.79M
Cost of Revenue
14.27M 18.02M 14.84M 14.6M 13.75M
Gross Profit
12.24M 20.24M 13.67M 16.42M 19.04M
Operating Income
-75.83M -9.17M -19.61M -17.27M -19.32M
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
-76.86M -10.24M -15.27M -17.66M -20.49M
Net Income
-76.29M -9.43M -13.84M -17.14M -18.82M
Selling & General & Admin
30.88M 22.96M 24.07M 24.25M 27.61M
Research & Development
8.87M 8.54M 9.21M 9.44M 10.75M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
39.74M 31.5M 33.28M 33.69M 38.36M
Interest Expense
1.03M 1.07M 968K 896K 887K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
54.01M 49.52M 48.12M 48.29M 52.11M
Income Tax Expense
-574K -814K -1.42M -517K -1.67M
Shares Outstanding (Basic)
77.03M 76.65M 76.3M 75.45M 74.71M
Shares Outstanding (Diluted)
77.03M 76.65M 76.3M 75.45M 74.71M
EPS (Basic)
-0.99 -0.12 -0.18 -0.23 -0.25
EPS (Diluted)
-0.99 -0.12 -0.18 -0.23 -0.25
EBITDA
-71.86M -5.29M -10.43M -12.87M -15.69M
EBIT
-75.83M -9.17M -14.3M -16.76M -19.61M
Depreciation & Amortization
3.97M 3.88M 3.87M 3.9M 3.92M